Elafibranor emerged as a potential chemotherapeutic drug for non-muscle invasive bladder cancer
{{output}}
Intravesical infusion of chemotherapeutics is highly recommended by several clinical guidelines for treating nonmuscle invasive bladder cancer (NMIBC). However, cytotoxic chemotherapeutics can cause a series of side effects, which greatly limits their applicat... ...
